New 52 Week Low Today

Immuneering Corp IMRX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:02 PM EDT
1.50UNCH (UNCH)
Volume
1,656
Close
1.50quote price arrow down-0.13 (-7.98%)
Volume
469,310
52 week range
1.47 - 12.15
Loading...
  • Open1.61
  • Day High1.65
  • Day Low1.47
  • Prev Close1.63
  • 52 Week High12.15
  • 52 Week High Date04/25/23
  • 52 Week Low1.47
  • 52 Week Low Date04/24/24

Key Stats

  • Market Cap43.925M
  • Shares Out29.28M
  • 10 Day Average Volume0.55M
  • Dividend-
  • Dividend Yield-
  • Beta-0.89
  • YTD % Change-79.59

KEY STATS

  • Open1.61
  • Day High1.65
  • Day Low1.47
  • Prev Close1.63
  • 52 Week High12.15
  • 52 Week High Date04/25/23
  • 52 Week Low1.47
  • 52 Week Low Date04/24/24
  • Market Cap43.925M
  • Shares Out29.28M
  • 10 Day Average Volume0.55M
  • Dividend-
  • Dividend Yield-
  • Beta-0.89
  • YTD % Change-79.59

RATIOS/PROFITABILITY

  • EPS (TTM)-1.89
  • P/E (TTM)-0.80
  • Fwd P/E (NTM)-0.77
  • EBITDA (TTM)-58.061M
  • ROE (TTM)-53.36%
  • Revenue (TTM)-
  • Gross Margin (TTM)100.00%
  • Net Margin (TTM)-11,224,720.00%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/07/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Immuneering Corp

 

Profile

MORE
Immuneering Corporation is a clinical-stage oncology company. The Company is engaged in the development of medicines for cancer patients with universal-RAS therapy. The Company’s lead product candidate, IMM-1-104, in under Phase I/IIa clinical trial in patients with advanced solid tumors harboring RAS mutations. IMM-1-104 is being developed as a once-daily oral monotherapy that aims to achieve universal-RAS activity through deep cyclic inhibition of the MAPK pathway. The...
Robert Carpenter
Independent Chairman of the Board, Co-Founder
Benjamin Zeskind Ph.D.
President, Chief Executive Officer, Co-Founder, Director
Mallory Morales
Principal Financial Officer, Principal Accounting Officer
Michael Bookman
General Counsel, Secretary, Chief Legal Officer
Address
245 Main St Fl 2
Cambridge, MA
02142
United States

Top Peers

SYMBOLLASTCHG%CHG
AVRO
AVROBIO Inc
1.19-0.02-1.65%
GANX
Gain Therapeutics Inc
3.19-0.20-5.90%
ABIO
ARCA Biopharma Inc
3.63-0.02-0.55%
LTRN
Lantern Pharma Inc
5.38-0.39-6.76%
IMMX
Immix Biopharma Inc
2.13-0.17-7.39%